Erik H Van Iterson1, Joshua R Smith2, Thomas P Olson2. 1. Preventive Cardiology and Cardiac Rehabilitation Section, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: vanitee@ccf.org. 2. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Abstract
BACKGROUND: Peak exercise pulmonary oxygen uptake (V̇O2) is a primary marker of prognosis in heart failure (HF). The pathophysiology of impaired peak V̇O2 is unclear in patients. To what extent alveolar airway function affects V̇O2 during cardiopulmonary exercise testing (CPET) has not been fully elucidated. This study aimed to describe how changes in alveolar ventilation (V̇A), volume (VA), and related parameters couple with exercise V̇O2 in HF. METHODS AND RESULTS: A total of 35 patients with HF (left ventricular ejection fraction 20 ± 6%, age 53 ± 7 y) participated in CPET with breath-to-breath measurements of ventilation and gas exchange. At rest, 20 W, and peak exercise, arterial CO2 tension was measured via radial arterial catheterization and used in alveolar equations to derive V̇A and VA. Resting lung diffusion capacity for carbon monoxide (DLCO) was assessed and indexed to VA for each time point. Resting R2 between V̇O2 and V̇A, VA, DLCO, and DLCO/VA was 0.68, 0.18, 0.20, and 0.07, respectively (all P < .05 except DLCO/VA). 20 W R2 between V̇O2 and V̇A, VA, DLCO, and DLCO/VA was 0.64, 0.32, 0.07, and 0.18 (all P < .05 except DLCO). Peak exercise R2 between V̇O2 and V̇A, VA, DLCO, and DLCO/VA was 0.55, 0.31, 0.34, and 0.06 (all P < .05 except DLCO/VA). CONCLUSIONS: These data suggest that alveolar airway function that is not exclusively related to effects caused by localized lung diffusivity affects exercise V̇O2 in moderate-to-severe HF.
BACKGROUND: Peak exercise pulmonary oxygen uptake (V̇O2) is a primary marker of prognosis in heart failure (HF). The pathophysiology of impaired peak V̇O2 is unclear in patients. To what extent alveolar airway function affects V̇O2 during cardiopulmonary exercise testing (CPET) has not been fully elucidated. This study aimed to describe how changes in alveolar ventilation (V̇A), volume (VA), and related parameters couple with exercise V̇O2 in HF. METHODS AND RESULTS: A total of 35 patients with HF (left ventricular ejection fraction 20 ± 6%, age 53 ± 7 y) participated in CPET with breath-to-breath measurements of ventilation and gas exchange. At rest, 20 W, and peak exercise, arterial CO2 tension was measured via radial arterial catheterization and used in alveolar equations to derive V̇A and VA. Resting lung diffusion capacity for carbon monoxide (DLCO) was assessed and indexed to VA for each time point. Resting R2 between V̇O2 and V̇A, VA, DLCO, and DLCO/VA was 0.68, 0.18, 0.20, and 0.07, respectively (all P < .05 except DLCO/VA). 20 W R2 between V̇O2 and V̇A, VA, DLCO, and DLCO/VA was 0.64, 0.32, 0.07, and 0.18 (all P < .05 except DLCO). Peak exercise R2 between V̇O2 and V̇A, VA, DLCO, and DLCO/VA was 0.55, 0.31, 0.34, and 0.06 (all P < .05 except DLCO/VA). CONCLUSIONS: These data suggest that alveolar airway function that is not exclusively related to effects caused by localized lung diffusivity affects exercise V̇O2 in moderate-to-severe HF.
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Massimo F Piepoli; Viviane Conraads; Ugo Corrà; Kenneth Dickstein; Darrel P Francis; Tiny Jaarsma; John McMurray; Burkert Pieske; Ewa Piotrowicz; Jean-Paul Schmid; Stefan D Anker; Alain Cohen Solal; Gerasimos S Filippatos; Arno W Hoes; Stefan Gielen; Pantaleo Giannuzzi; Piotr P Ponikowski Journal: Eur J Heart Fail Date: 2011-04 Impact factor: 15.534
Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer Journal: Eur Heart J Date: 2016-05-20 Impact factor: 29.983